🇺🇸 FDA
Patent

US 10100367

Diagnosing and monitoring CNS malignancies using microRNA

granted A61KA61K31/517

Quick answer

US patent 10100367 (Diagnosing and monitoring CNS malignancies using microRNA) held by The Regents of the University of California expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/517